Importantly, treatment with the CRBN-mediated degraders on prostate cancer cells induces a pronounced inhibitory effect on both AR and MYC signaling axes and elicited a markedly inhibitory effect on cell growth and stimulatory on cell apoptosis [291]. This evidence concerns the gene MYC and prostate carcinoma.